The Costly burden of drug-resistant TB in the United States

Multidrug-resistant (MDR) tuberculosis is a major health threat globally. Nearly half a million MDR TB cases are estimated to occur worldwide annually, including cases that are extensively drug-resistant (XDR).While MDR and XDR TB are relatively rare in the U.S., their treatment comes at a terrible price \u2013 it is very expensive, takes a long time to treat, disrupts lives, and has potentially life-threatening side effectscostly-burden-dr-tb-508.pdf201